Pfizer Partners With BioNTech On Flu Vaccines.

Reuters (8/16) reports Pfizer has entered a deal with BioNTech under which the companies will collaborate on new flu shots. Pfizer will pay the biotech “$120 million upfront plus up to $305 million depending on certain development achievements as well as...